Hematology and Medical Oncology

News

Q & A with Anant Madabhushi, director of the Emory Empathetic AI for Health Institute.

Findings from the LAURA Phase III trial — presented at the ASCO Annual Meeting by Winship Executive Director Suresh Ramalingam, MD, and simultaneously published in The New England Journal of Medicine — show osimertinib significantly extends the time patients live without their cancer worsening, offering the first effective therapy and new hope for those with advanced EGFR-mutated non-small cell lung cancer.

President Biden has appointed Edjah K. Nduom, MD, to the National Cancer Advisory Board.

Events

Loading Events...